Protein-based Degrader Strategies against Oncogenic RAS
Targeted therapies have emerged as a promising cancer treatment strategy by inhibiting proteins specific to cancer cells while preserving healthy cells. RAS proteins play a crucial role in cancer development and are associated with increased tumor growth and invasion. Mutations in RAS genes, especia...
Main Author: | Cheah, Keith M. |
---|---|
Other Authors: | Wittrup, K. Dane |
Format: | Thesis |
Published: |
Massachusetts Institute of Technology
2023
|
Online Access: | https://hdl.handle.net/1721.1/151504 |
Similar Items
-
Targeting immunosuppression in the tumor microenvironment and protein-based antagonism of oncogenic K-Ras
by: Kauke, Monique Jacqueline
Published: (2018) -
Activation of the c-Ha-ras oncogene
by: Tabin, Clifford James.
Published: (2024) -
Autophagic activity dictates the cellular response to oncogenic RAS.
by: Wang, Y, et al.
Published: (2012) -
Intrabodies based on intracellular capture frameworks that bind the RAS protein with high affinity and impair oncogenic transformation.
by: Tanaka, T, et al.
Published: (2003) -
Pharmacological modulation of oncogenic Ras by natural products and their derivatives: renewed hope in the discovery of novel anti-Ras drugs
by: Quah, Shun Ying, et al.
Published: (2016)